MarketCap
Facebook
X
TelegramAnnual report 2025
added 11-25-2025
Becton, Dickinson and Company Total Shareholders Equity 2011-2026 | BDX
Annual Total Shareholders Equity Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.4 B | 25.9 B | 25.8 B | 25.3 B | 23.7 B | 23.8 B | 21.1 B | 21 B | 12.9 B | 7.63 B | 7.16 B | 5.05 B | 5.04 B | 4.14 B | 4.83 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.9 B | 4.14 B | 15.9 B |
Quarterly Total Shareholders Equity Becton, Dickinson and Company
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.5 B | 25.2 B | 25.2 B | 25.9 B | 25.6 B | 25.3 B | 25.9 B | 25.7 B | 25.5 B | 25.3 B | - | 24.5 B | 24.2 B | 23.7 B | 24.1 B | 23.7 B | 24.7 B | 23.8 B | 23.8 B | 23.8 B | 21.2 B | 21.1 B | 21.1 B | 21.1 B | 21.4 B | 21 B | 21 B | 21 B | 21.2 B | 12.9 B | 12.9 B | 12.9 B | 7.58 B | 7.63 B | 7.63 B | 7.63 B | 7.22 B | 7.16 B | 7.16 B | 7.16 B | 5.07 B | 5.05 B | 5.05 B | 5.05 B | 5.08 B | 5.04 B | 5.04 B | 5.04 B | 4.47 B | 4.14 B | 4.14 B | 4.14 B | 4.73 B | 4.83 B | 4.83 B | 4.83 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.9 B | 4.14 B | 15.2 B |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
6.96 B | $ 20.07 | - | $ 10.2 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
12.7 M | $ 8.7 | - | $ 175 M | USA |
 |
ICU Medical
ICUI
|
1.97 B | $ 149.9 | - | $ 3.66 B | USA |
 |
Alcon
ALC
|
18.8 B | $ 80.98 | - | $ 40.4 B |  Schweiz |
 |
InfuSystem Holdings
INFU
|
48 M | $ 8.26 | - | $ 171 M | USA |
 |
AtriCure
ATRC
|
461 M | $ 36.93 | - | $ 1.73 B | USA |
 |
electroCore
ECOR
|
7.44 M | $ 6.66 | -6.2 % | $ 36.7 K | USA |
 |
Haemonetics Corporation
HAE
|
821 M | $ 66.66 | - | $ 3.35 B | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 10.36 | - | $ 423 M | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 81.38 | 1.26 % | $ 16.2 B | USA |
 |
Harvard Bioscience
HBIO
|
73.1 M | $ 0.5 | -6.65 % | $ 21.2 M | USA |
 |
Merit Medical Systems
MMSI
|
1.38 B | $ 81.09 | - | $ 4.72 B | USA |
 |
Glaukos Corporation
GKOS
|
462 M | $ 119.38 | - | $ 5.78 B | USA |
 |
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.39 | -1.1 % | $ 246 M | USA |
 |
OraSure Technologies
OSUR
|
410 M | $ 2.79 | - | $ 208 M | USA |
 |
iRhythm Technologies
IRTC
|
90.9 M | $ 154.51 | 3.7 % | $ 4.82 B | USA |
 |
LeMaitre Vascular
LMAT
|
337 M | $ 84.97 | - | $ 1.91 B | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 137.33 | - | $ 7.32 B | USA |
 |
Intuitive Surgical
ISRG
|
16.4 B | $ 504.22 | - | $ 179 B | USA |
 |
STERIS plc
STE
|
6.6 B | $ 262.6 | - | $ 25.9 B | USA |
 |
Microbot Medical
MBOT
|
4.5 M | $ 1.8 | - | $ 18.4 M |  Israel |
 |
Nephros
NEPH
|
8.36 M | $ 4.31 | -1.82 % | $ 44.8 M | USA |
 |
Milestone Scientific
MLSS
|
5.83 M | $ 0.28 | - | $ 22.3 M | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
128 M | $ 61.06 | - | $ 222 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.93 B | $ 23.47 | - | $ 4.04 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 12.47 | - | $ 2.53 B | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 39.23 | -0.44 % | $ 129 M | USA |
 |
Predictive Oncology
POAI
|
-203 K | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 13.83 | - | $ 664 M | USA |
 |
Repligen Corporation
RGEN
|
1.96 B | $ 149.37 | - | $ 8.32 M | USA |
 |
ResMed
RMD
|
3.36 B | $ 258.31 | 0.27 % | $ 37.7 B | USA |
 |
BioLife Solutions
BLFS
|
349 M | $ 21.8 | - | $ 1 B | USA |
 |
Stereotaxis
STXS
|
16.3 M | $ 2.19 | -6.01 % | $ 177 M | USA |
 |
Retractable Technologies
RVP
|
87.2 M | $ 0.7 | - | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
397 M | $ 18.95 | - | $ 931 M | USA |
 |
Teleflex Incorporated
TFX
|
4.28 B | $ 104.37 | - | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
2.68 B | $ 231.12 | - | $ 16.9 B | USA |